The Asia-Pacific Oncology Alliance (APOA) is a project within the Pinnacle Program. Bringing together stakeholders from across the cancer continuum, the Alliance has a shared vision of better access to cancer care and treatment for the billions of people in the Asia-Pacific region. Find out more about APOA.
In first APOA webinar, we explored the exciting developments in global cancer care, how it is changing for the better, and what this means for the Asia-Pacific region.
We heard from a range of cancer care experts (see speaker bios below), including:
- Dr Angie Sievert-Fernandez: Executive Director, Kythe Foundation Inc. (Philippines)
- Dr Nur Amalina Che Bakri: Clinical Research Fellow, Department of Surgery and Cancer of Imperial College London
- Dr Toshio Shimizu: Professor, Wakayama Medical University Hospital
- Dr Khoo Yoong Khean: Scientific Officer, Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS)
- Prof Victoria Elegant: Global Lead, Access to Medicines, Amgen
- Richard Vines: Co-Founder and Chief Executive, Rare Cancers Australia
Watch the webinar:
Dr Angie Sievert-Fernandez: Executive Director, Kythe Foundation Inc. (Philippines)
Angie is a Registered Psychologist, a Certified Specialist in Counselling and Developmental Psychology by the Psychological Association of the Philippines and is one of only three Certified Child Life Specialists in the country as certified by the Child Life Council, USA. Currently, Dr. Angie is the Executive Director of Kythe Foundation Inc, the only organization in the Philippines providing child life services to children with cancer and other chronic illnesses in partner hospitals nationwide.
Dr Nur Amalina Che Bakri: Clinical Research Fellow, Department of Surgery and Cancer of Imperial College London
Dr Bakri has been recognised as one of Asia’s top medical minds who are leading progress against cancer. Dr Bakri received her medical degree in 2013 from the University of Edinburgh. She was recently appointed as an Ambassador for Genomics England and works with Public Health England (NHS). Dr Bakri is also known for harnessing the power of social media to promote medical knowledge, and is an advocate for accurate and reliable healthcare information.
Dr Toshio Shimizu: Professor, Wakayama Medical University Hospital
Dr. Toshio Shimizu is Professor at Wakayama Medical University Hospital and Associate Professor at Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Graduate School of Medicine, Wakayama Japan. Before joining Wakayama Medical University, he served as a Head of Physician at Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo Japan during 2016-2022.
Dr Khoo Yoong Khean: Scientific Officer, Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS)
Dr Khoo Yoong Khean is a Scientific Officer at the Centre of Regulatory Excellence (CoRE), Centre for Outbreak Preparedness (COP) and SingHealth Duke-NUS Global Health Institute (SDGHI) at the Duke-NUS Medical School, Singapore. He is a medical doctor by training with experience in clinical medicine, clinical data analysis and previously volunteered as a humanitarian aid worker. His current work focuses on global health policies and health systems strengthening. Under CoRE, he leads the patient engagement portfolio to increase patient involvement in the development and regulation of health products and services.
Prof Victoria Elegant: Global Lead, Access to Medicines, Amgen
Prof Elegant is a physician who joined the pharmaceutical industry after postgraduate training in obstetrics and gynaecology in the United Kingdom. She has held positions in global drug development, medical affairs, regulatory affairs and drug safety in Japan, Australia, Europe and the Asia Pacific. She is the President of the Asia Pacific chapter of the Medical Affairs Professional Society (MAPS), on the global MAPS Board, and a member of the Faculty of Pharmaceutical Medicine Global Forum.
Richard Vines: Co-Founder and Chief Executive, Rare Cancers Australia
In 2012 Richard and his wife Kate established Rare Cancers Australia, a patient organisation whose mission is to improve the lives and outcomes for rare cancer patients. The organisation has become recognised as a leader in the broader cancer community. Richard is Chair and Chief Executive of Rare Cancers Australia, Convener and Co-chair of the National Oncology Alliance and Deputy Chair of the Australian Genomics Cancer Medicines Centre (OMICO).